Drug Database
TR

transdermal system (TransPhase)

✓ Approved

Transdermal · 治疗药物

什么是 transdermal system?

transdermal system 是一种治疗药物,由Transdermal研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。

药物档案

商品名TransPhase
公司Transdermal
给药途径Transdermal
状态Approved

治疗适应症

transdermal system 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresOral appliance application✓ Approved

相关研究文献

PubMedRoyal Society open science2026-11-18

Photographic assessment of tissue responses to consolidated implantable telemetry tags in southern right whales (Eubalaena australis).

Uhart Marcela M MM, Fernández Santiago J SJ, Vanstreels Ralph E T RET, Gulland Frances M D FMD et al.

Implantable satellite tags provide critical information on whale movements, but information on tag-related wound healing remains limited. We assessed wound progression using photography in southern right whales (Eubalaena australis) instrumented with fully integrated consolidated satellite tags anchored below the fascia (transdermal/subfascial; n = 19) or within the blubber (blubber-only/supra-fascial; n = 22) regularly for up to 70 days post-deployment and opportunistically using long-term resightings up to 71 months post-tagging. External tag wounds followed a predictable sequence of localized swelling, tissue extrusion, remodelling and stabilization. Several wound features varied with tag design and deployment characteristics, including tag surface, anatomical position on the whale and deployment angle. Despite these differences, tissue responses remained localized and progressed predictably, with no photographic evidence of abnormal wound evolution or substantial externally apparent shear-related tissue damage. Contrary to expectations, more superficially implanted blubber-only tags did not produce milder external tissue responses than transdermal tags during the observation period. These findings support standardized photograph-based assessment as a practical approach for evaluating tag effects and guiding refinements in tag design and deployment.

PMID 43048723
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

A Prospective, Active-Controlled Split-Face Clinical Trial Evaluating the Incremental Aesthetic Benefits of a Glutathione-Containing Booster in a GHK-Conjugated Spicule Regimen.

Noh Seongmin S, Hong Wonkyu W, Choi Hosung H, Park Youngjin Y et al.

Transdermal delivery of hydrophilic peptides such as GHK remains limited by the stratum corneum barrier and the classical 500 Da rule. Spicule-based systems and redox-responsive linkages have been investigated as strategies to enhance epidermal delivery, but in vivo glutathione-triggered cleavage remains a proposed mechanism rather than a clinically proven process. This study aimed to evaluate the clinical efficacy and safety of a GHK-conjugated spicule regimen and to determine whether adding a multi-ingredient, glutathione-containing booster provides incremental aesthetic benefit compared with the shared base regimen alone. In this prospective, active-controlled split-face clinical trial, 20 healthy Asian women received five weekly facial treatments. One prespecified facial side received the base regimen consisting of a GHK-conjugated spicule system and base concentrate, while the contralateral side received the same base regimen plus a separate multi-ingredient booster containing 1% glutathione. Wrinkle depth, pore parameters, skin elasticity, dermal density, surface roughness, and pigmentation were evaluated at baseline, after one and three treatment sessions, and 4 weeks after the fifth session. Between-side comparisons were performed using change-from-baseline values, with prespecified primary endpoints, multiplicity adjustment, and effect-size reporting. Both sides showed improvements from baseline. At the final timepoint, the intensive regimen produced greater improvements than the base regimen in periorbital wrinkle depth (-0.0144 vs. -0.0084 mm), nasolabial wrinkle depth (-0.0227 vs. -0.0173 mm), dermal density (+7.27 vs. +4.49), roughness (-1.23 vs. -0.73 μm), and mean pore volume (-0.0007 vs. -0.0005 mm3). Multiplicity-adjusted between-side differences remained significant for the prespecified primary endpoints and secondary endpoints. No adverse effects were reported. The GHK-conjugated spicule base regimen improved multiple facial aging indicators, and the booster-inclusive intensive regimen produced statistically greater short-term improvements in this small split-face trial. Because the booster was multi-ingredient and the release mechanism was not directly measured in vivo, these findings should be interpreted as regimen-level clinical evidence rather than proof of glutathione-specific redox cleavage. TRN Registration Number: PRE20250909-005.

PMID 43047164
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Carboxytherapy in Androgenetic Alopecia: Hype or Hope?

Mokhtari Fatemeh F, Shafiei Hamzeh H, Faghihi Gita G, Mohamadsalehi Azin A

Androgenetic alopecia (AGA) is the most common type of hair loss in men and can impose a significant psychosocial burden, reducing self-esteem and quality of life. Current standard treatments include topical minoxidil and oral finasteride; however, there is no definitive or fully satisfactory treatment. Carboxytherapy increases blood flow and enhances the delivery of oxygen and nutrients to hair follicles. It may also facilitate transdermal drug delivery and improve the response to standard therapy. Forty-six male patients aged 18-50 years with moderate-to-severe androgenetic alopecia (AGA) were allocated into two groups. The intervention group received topical minoxidil 5%, oral finasteride 1 mg, and carboxytherapy. A total of six sessions were administered at 2-week intervals over approximately 12 weeks. The control group received topical minoxidil 5% and oral finasteride 1 mg alone. Outcomes were assessed at baseline, 3 months, and 24 weeks post-treatment using standardized photography, dermoscopy, and patient satisfaction based on a 7-point grading scale. At 24 weeks post-treatment, both groups showed statistically significant improvements in patient satisfaction and photography-dermoscopy scores. However, the intervention group achieved significantly higher dermoscopy-photography scores than the control group (p = 0.006). Adding carboxytherapy to standard therapy (topical minoxidil and oral finasteride) resulted in greater clinical improvement and higher patient satisfaction compared with standard therapy alone.

PMID 43047050
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Microneedling for the Treatment of Acne Scars: A Scoping Review of Therapeutic Protocols, Combination Therapies, and Current Evidence.

Castellano Luca L, Capponi Angela A, Rovatti Pier Paolo PP, Campomagnani Elisa E et al.

Atrophic acne scarring is a complex condition with no definitive single treatment. Microneedling (MN) is a safe alternative to ablative procedures because it preserves the epidermis, minimizing the risk of post-inflammatory hyperpigmentation. This scoping review maps the available literature on the technical parameters, multimodal protocols, and knowledge gaps associated with mechanical MN for acne scar revision. Following JBI and Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines, a systematic search was conducted across PubMed and Scopus for English-language articles published over the last decade. Both primary clinical research and secondary evidence syntheses evaluating manual and motorized mechanical MN were included. A total of 85 studies met the inclusion criteria. Extracted data reveal a dichotomy between manual dermarollers and motorized pens, with penetration depths ranging from 0.5 to 3.0 mm. Because MN monotherapy shows limited efficacy for complex lesions, current protocols have shifted clearly toward multimodal regimens. MN is frequently combined with surgical subcision, chemical peels, and transdermal agents. Platelet-Rich Plasma (PRP) is the most widely utilized adjunct, while topical human insulin is emerging as a promising alternative. The mapped evidence supports MN as a safe bridging intervention for multimodal scar management. However, this review identifies a critical methodological gap: the pervasive reliance on truncated follow-up periods (1 to 3 months). This abbreviated timeline predominantly captures transient inflammatory edema rather than definitive neocollagenesis, risking an overestimation of long-term efficacy. Future clinical trials must implement a minimum follow-up of 6 to 12 months alongside objective biometric assessments.

PMID 43047300
阅读全文 →
PubMedIsrael journal of health policy research2026-11-18

Identifying healthcare system barriers among parents of children with disabilities: segmentation and importance-performance analyses.

Gilboa Shaked S, Vilnai-Yavetz Iris I, Seger-Guttmann Tali T, Schertz Mitchell M et al.

Healthcare system barriers impose substantial physical, emotional and administrative burdens on parents of children with disabilities. Past research has classified parents based on the child's disability or degree of medical complexity. The purpose of the present study is to identify distinct groups of parents of children with disabilities based on parents' subjective experience with the healthcare system and to examine differences in healthcare system barriers across these groups to inform more tailored policy interventions. A cross-sectional survey was conducted among a representative sample of Jewish parents of children with disabilities in Israel (N = 537). Segmentation analysis was performed based on perceived effort invested in claiming health entitlements and satisfaction from success in realizing those entitlements. Separate importance-performance analyses (IPA) were conducted for each identified group to identify high-priority system barriers. Two parent segments were identified. Balanced Navigators were characterized by lower perceived effort and higher satisfaction with the realization of rights, whereas Heavy-Laden Navigators were marked by higher perceived effort and lower satisfaction with the realization of rights. Further analysis showed that a larger proportion of the Heavy-Laden Navigators used private health services (medical experts and allied health therapies) for their children. The demographics of the two groups differed with respect to gender, education, ability to meet monthly expenses, and parenting multiple children with disabilities. IPA revealed that Heavy-Laden Navigators faced a broader range of critical barriers, particularly availability of clear system information, access to specialists and allied health appointments, challenges associated with obtaining authorizations and reimbursements, inner-coordination among healthcare professionals and with educational staff, and difficulties in exercising eligibility for medical equipment. Healthcare system barriers are unevenly distributed among parents of children with disabilities. This study's segmentation-based approach combined with IPA offers a practical framework for identifying high-burden parent groups based on their own experience and prioritizing policy actions to improve equity, coordination, and access to care.

PMID 43046090
阅读全文 →
PubMedZoonoses (Shannon, Ireland)2026-11-18

Epidemiology of Campylobacteriosis Reported to the Foodborne Diseases Active Surveillance Network (FoodNet), the National Notifiable Disease Surveillance System (NNDSS), and the National Outbreak Reporting System (NORS), United States, 2004-2023.

Weller Daniel L DL, Verlander Sarah S, Bitting Jessica J, Boxrud David D et al.

Campylobacteriosis is monitored by several U.S. surveillance systems, including the Foodborne Diseases Active Surveillance Network (FoodNet), the National Notifiable Diseases Surveillance System (NNDSS), and the National Outbreak Reporting System (NORS). FoodNet conducts active surveillance across 10 sites, while NNDSS conducts national passive surveillance, and NORS captures data on outbreaks. Understanding the similarities and differences among these systems is essential for informing prevention and reducing disease burden. We analyzed data reported to each system during 2004-2023. Trends were modeled using spline regression, and incidence rate ratios were used to characterize changes in epidemiology. The clinical and patient characteristics of illnesses reported to FoodNet and NNDSS were similar. Both systems showed a sustained increase in incidence starting in 2010, with increasing concordance after 2015. The results support the use of NNDSS for monitoring national trends. Adoption of culture-independent diagnostic tests (CIDT) likely drove some of the increase in the reported campylobacteriosis incidence, but cannot fully explain it. Moreover, because outbreak frequency remained stable during 2004-2023 but outbreak size decreased, the increases in campylobacteriosis incidence observed were probably driven by sporadic rather than outbreak-associated illness. This underscores the need for enhanced attribution methods and strengthened prevention strategies to better understand and address non-CIDT factors contributing to this increase.

PMID 43048255
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多transdermal system